As of November 6, 2026, SenesTech, Inc. is a publicly traded company (Nasdaq: SNES). The largest holder reporting an active stake on Schedule 13D is Glenbrook Capital Management, at 40.51%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include PFS Cap Mgt Co (9.99%), Fakhoury Ranni Emad (5%) (Schedule 13D/A, October 30, 2026).
Is this your company?
About to sign with, pay or invest in SenesTech, Inc.? See the free Snapshot first.
Free to see. No signup.
Is SenesTech, Inc. a real, registered company?
- SenesTech, Inc. files with the SEC under CIK 1680378 (its SEC filings).
- Its shares are listed under the ticker SNES on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Phoenix, Arizona, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under SenesTech, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Michael Edell, President and Chief Executive Officer (Form 8-K filed 2026-05-07). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Glenbrook Capital Management (filed 2026-10-30).
Who are SenesTech, Inc.'s owners and officers?
SenesTech, Inc.: incorporated in Delaware; business address in Phoenix, Arizona; industry Agricultural Chemicals (Schedule 13D/A, 2026-10-30).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer (Form D, 2025-08-12)
- : Executive Officer, Director (Form D, 2025-08-12)
- : Director (Form D, 2025-08-12)
- : Director (Form D, 2025-08-12)
- : Director (Form D, 2025-08-12)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-10-30 | Glenbrook Capital Management | 40.51% |
| Schedule 13G, 2026-10-30 | Fakhoury Ranni Emad | 5% |
| Schedule 13D, 2026-10-26 | Lebeau Justin Michael | 5.4% |
| Schedule 13D/A, 2026-10-22 | Glenbrook Capital Management | 39.95% |
| Schedule 13D/A, 2026-10-19 | Glenbrook Capital Management | 38.04% |
| Schedule 13D, 2026-07-23 | Glenbrook Capital Management | 19.95% |
| Schedule 13G/A, 2026-03-18 | Glenbrook Capital Management | 16.8% |
| Schedule 13G/A, 2026-02-02 | Glenbrook Capital Management | 11.4% |
| Schedule 13G, 2025-11-24 | Glenbrook Capital Management | 9.99% |
| Schedule 13G/A, 2025-08-12 | Pfs Cap Mgt Co | 9.99% |
Questions about who owns SenesTech, Inc.
Who owns SenesTech, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of SenesTech, Inc.: Glenbrook Capital Management (40.51%, Schedule 13D/A, filed 2026-10-30), Pfs Cap Mgt Co (9.99%, Schedule 13G/A, filed 2025-08-12), Lebeau Justin Michael (5.4%, Schedule 13D, filed 2026-10-26) and Fakhoury Ranni Emad (5%, Schedule 13G, filed 2026-10-30).
Who are the largest shareholders of SenesTech, Inc.?
By the share each holder's latest filing reports, the largest holders of SenesTech, Inc. on this page are Glenbrook Capital Management (40.51%), Pfs Cap Mgt Co (9.99%) and Lebeau Justin Michael (5.4%).
When did Glenbrook Capital Management buy into SenesTech, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Glenbrook Capital Management on this page is the Schedule 13G, filed 2025-11-24, reporting 9.99%; its latest, Schedule 13D/A filed 2026-10-30, reports 40.51%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on SenesTech, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on SenesTech, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SenesTech, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
20 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-05-07 | Michael Edell | President and Chief Executive Officer | appointed |
Which insiders own SenesTech, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Glenbrook Capital Management, a 10% owner: 4,391,946 shares (81.0% of shares outstanding), held indirectly (the form names the holder only in its footnotes) (Form 4, 2026-10-30).
- , the chief executive and a director: 11,000 shares (0.20% of shares outstanding) (Form 4, 2026-09-29).
Shares outstanding: 5,423,542 as of 2026-08-04, from the company's latest SEC cover page.
How much has SenesTech, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-08-12 | $274K | $274K |
| Form D, 2025-07-14 | $182K | $182K |
| Form D, 2025-03-25 | $0 | not stated |
| Form D, 2024-08-30 | $0 | not stated |
| Form D, 2023-09-06 | $0 | not stated |
| Form D, 2023-04-26 | $1.50M | $1.50M |
Keep reading
More on SenesTech, Inc. and the records around it.
SenesTech, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes May 2026
Companies that share a holder
- GLENBROOK CAPITAL MANAGEMENT also filed stake reports on 1 other company: INVO Fertility, Inc. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/senestech